Skip to main content

Table 1 Demographic and clinical characteristics of study population (n = 62)

From: Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study

Clinical characteristics

N/n of Patients (%)

Age at diagnosis

  < 40

2/62(3.2%)

 40~50

18/62 (29.0%)

 50~60

20/62 (32.3%)

 60~70

18/62 (29.0%)

  ≥ 70

4/62 (6.5%)

FIGO stage

 I

6/62(9.7%)

 II

5/62 (8.1%)

 III

36/62 (58.1%)

 IV

9/62 (14.5%)

 NAa

6/62 (9.7%)

Primary or Recurrent

 Primary

48/62 (77.4%)

 Recurrent

14/62 (22.6%)

Tumor histopathology

 High-gradeb serous

48/62 (77.4%)

 Clear cell

5/62 (8.1%)

 Endometrioid

3/62 (4.8%)

 Low-gradec serous

1/62 (1.6%)

 Mucinous

1/62 (1.6%)

 Othersd

4/62 (6.5%)

Self, in addition to ovarian cancer

 Breast cancer

5/62(8.1%)

 No breast cancer

18/62 (91.9%)

Family history

 Breast cancer

3/62(4.8%)

 Ovarian cancer

7/62 (11.3%)

 Pancreatic cancer

1/62(1.6%)

 Pancreatic cancer

1/62(1.6%)

 Colon cancer

2/62(3.2%)

 Other cancer

18/62(29.0%)

 Breast or ovarian cancer

10/62(16.1%)

  1. a: NA = Not Available
  2. b: Grades 2–3
  3. c: Grade 1
  4. d: Other = one malignant Brenner, one squamous cell carcinoma, one mixed carcinomas, and one unclassified adenocarcinoma